MPS peptide, a 25-mer peptide targeting PSD, not only suppresses lung cancer metastasis, but also inhibits tumor growth in vivo by decreasing levels of phospho-MARCKS, phosphatidylinositol (3,4,5)-triphosphate, and AKT activity [63]. This evidence concerns the gene MARCKS and neoplasm.